Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.

Richard Jefferys, an expert in HIV cure research, spoke to TheBodyPro about this new case of HIV remission -- and the danger in rushing to publish these stories, especially for people who live with stigma.

A new class of cancer drugs -- topoisomerase inhibitors -- is now in use in the United States for treating certain cancers. But despite laboratory studies and other reason to believe that these drugs might also work as antiretrovirals, they have neve...